NCT04586556

Brief Summary

The investigators hypothesize that the clinical implementation of a deep learning AI system is an optimal tool to monitor, audit and improve the detection and classification of polyps and other anatomical landmarks during colonoscopy. The objectives of this study are to generate preliminary data to evaluate the effectiveness of AI-assisted colonoscopy on: a) the rate of detection of adenomas; b) the automatic detection of the anatomical landmarks (i.e., ileocecal valve and appendiceal orifice).

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
372

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2020

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2020

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 14, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

December 18, 2020

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 11, 2022

Completed
Last Updated

November 25, 2022

Status Verified

November 1, 2022

Enrollment Period

1.3 years

First QC Date

October 1, 2020

Last Update Submit

November 23, 2022

Conditions

Keywords

Polyps detectionArtificial IntelligenceAdenoma detectionPolyps classificationQuality indicators

Outcome Measures

Primary Outcomes (2)

  • Number of polyps detected

    Efficacy of AI assisted colonoscopy to detect the proportion of patients with at least 1 polyp. Polyp detection rate with an AI.

    Day 1

  • Evaluation of the automatic report of the colonoscopy quality indicators

    Compare of the automatic detection of the ileocecal valve, appendiceal orifice, and the automatic calculation of the withdrawal time with manual detection

    Day 1

Study Arms (1)

Artificial intelligence for real-time detection and monitoring of colorectal polyps

EXPERIMENTAL

A standard colonoscopy will be performed according to the standard of routine care. All optically diagnosed polyps will be removed and sent to the CHUM pathology laboratory for histopathological evaluation according to institutional standards. The AI system will capture video of the procedure in real time, and provide additional information on the detection of polyps, follow-up and prediction of pathology. The full-length colonoscopy videos will be annotated for the exact time of the identification of the anatomical landmarks, polyps, also for polyp- and procedural-related characteristics.

Diagnostic Test: Polyps detection by Artificial Intelligence

Interventions

The AI system will capture the live video of the procedure and the AI feedback (polyp detection, tracking, and pathology prediction) will be shown on a second screen installed next to the regular endoscopy screen. Screen A will show the regular endoscopy image and screen B will show the regular endoscopy image together with the areas that might harbor a polyp or the information to predict pathology

Artificial intelligence for real-time detection and monitoring of colorectal polyps

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Age 45-80 years
  • Indication to undergo a lower GI endoscopy.

You may not qualify if:

  • Coagulopathy
  • Poor general health, defined as an American Society of Anesthesiologists (ASA) physical status class \>3
  • Emergency colonoscopies
  • Hospitalized patients
  • Known inflammatory bowel disease (IBD)
  • Patients currently in the emergency room

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Université de Montréal

Montreal, Quebec, QC H3T 1J4, Canada

Location

Centre Hospitalier Universitaire de Montréal

Montreal, Quebec, Canada

Location

IHU Strasbourg

Strasbourg, 67000, France

Location

MeSH Terms

Conditions

Adenomatous Polyps

Condition Hierarchy (Ancestors)

AdenomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasms

Study Officials

  • Daniel von Renteln

    Centre hospitalier de l'Université de Montréal (CHUM)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: prospective, multi-endoscopist, single center, clinical study at tertiary referral center (CHUM)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2020

First Posted

October 14, 2020

Study Start

December 18, 2020

Primary Completion

March 31, 2022

Study Completion

May 11, 2022

Last Updated

November 25, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations